What is the pay-off to enlisting celebrity endorsers? Although effects on stock returns are relatively well documented, little is known about any impact on sales-arguably a metric of more direct importance to advertising practitioners. In this study of athlete endorsements, we find there is a positive pay-off to a firm's decision to sign an endorser, and that endorsements are associated with increasing sales in an absolute sense and relative to competing brands. Furthermore, sales and stock returns jump noticeably with each major achievement by the athlete. However, whereas stock-return effects are relatively constant, sales effects exhibit decreasing returns over time. We outline implications for practitioners.
INTRODUCTION
What is the pay-off to enlisting celebrity endorsers? Although the use of endorsers has become a common practice in the world of advertising -by some estimates, 14% to 19% of advertisements that aired in the United States in recent years featured celebrities that endorsed products and brands, and the number was over twice as high in certain foreign markets (Creswell 2008) -extant research provides an incomplete picture of the effect of such endorsements. Most pressingly, while several studies give insight into how a firm's stock price tends to react when the firm signs a celebrity endorser (e.g., Agrawal and Kamakura 1995, Ding, Molchanov and Stork 2010) or when something happens to that endorser's reputation or status over the course of a celebrity's partnership with a brand (e.g., Mathur, Mathur and Rangan 1997, Louie, Kulik and Jacobson 2001) , the impact of such events on sales are poorly understood (e.g., Creswell 2008) . That is particularly unfortunate because sales movements are often more directly relevant to advertising and marketing practitioners than stock-price movements are, for instance when it comes to understanding what might be reasonable fees for endorsers, how compensation schemes can best be structured, whether a celebrityendorsement strategy fits an advertising campaign designed to help a brand gain market share over competing brands (or merely lift the category as a whole), and how distribution levels and other marketing-mix instruments are to be managed over the course of the endorsement.
In this study, we examine the impact of celebrity endorsements on sales and, to facilitate comparisons with extant research, stock returns. We focus on firms in a wide variety of consumergoods categories (ranging from bottled water and chewing gum to cameras and cosmetics) that enlist the services of professional athletes as endorsers. Although any focus on a particular type of celebrity may hinder generalizations to the wider population of celebrity endorsers, athletes are excellent subjects to study for a number of reasons. First, sportspeople are among the most popular endorsers ----- Figure 1 -----Research on Stock Returns. Agrawal and Kamakura (1995) examine 110 celebrity endorsements announced between 1980 and 1992. The authors find evidence of a positive impact: they report a (statistically significant) 0.44% abnormal return on the announcement date, and a 0.54% abnormal return over a two-day event period. In a small-sample study involving only three brands that announced an endorsement deal with golfer Tiger Woods some time prior to 1996, Farrell et al (2000) document positive one-day and two-day abnormal returns for two of the three brands. Fizel et al (2008) assess 148 athlete endorsements announced between 1994 and 2000, but exclude observations for what they term "megastars" which they fear may cause an upward bias.
They report no significant overall effect on stock prices on the announcement day or during other reasonable event windows. However, they do not reveal the magnitude of the presumed bias, making it difficult to interpret their results. Most recently, Ding et al (2010) analyze a sample of 101 celebrity announcements made between 1996 and 2008; they also document statistically insignificant abnormal returns around the announcement dates. Findings on possible determinants of these effects are also mixed. For instance, testing the so-called "match-up" hypothesis, Ding et al (2010) report weak support for the notion that endorsements representing a proper match between endorsers and products (e.g., an athlete promoting a sports drink rather than an alcoholic beverage) are more effective, while Fizel et al (2008) report no support for such a "congruence" effect.
The first of three studies to focus on events involving endorsers already aligned with firms, Mathur et al (1997) focus on one athlete, Michael Jordan, and examine the impact of his anticipated return to professional basketball in 1995 on the market value of the five firms he endorsed at the time as well as on the stock returns of 9 competing firms. They find a nearly 2% increase in stock returns for the endorsed brands, corresponding with more than $1 billion in market value, and significantly greater effects for endorsed firms than for non-endorsed firms. As the authors point out, however, because of the small sample of brands and because the focal athlete was the leading endorser at the time of the study, it remains unclear whether the findings generalize to a larger sample. A second study by Farrell et al (2000) , which again (as mentioned) only involves one athlete, Tiger Woods, examines stock-return movements for three brands as a function of the golfer's appearance and performance at 46 tournaments from 1996 to 1998. While Farrell et al (2000) provide little insight in the magnitude and significance of abnormal return movements during the tournaments, they do report that Woods' athletic performance is a significant driver of returns for only one brand, Nike, and not for American Express and Fortune Brands (which owns the golfing equipment brand Titleist). Again, however, the study's small sample size casts doubts upon the wider applicability of the findings. Finally, Louie et al (2001) investigate what happens to a firm's stock price when its celebrity endorser becomes involved in an undesirable event. Their data cover 48 such events and 128 endorsed brands. The authors report a statistically significant negative impact of undesirable events -an effect that is greatest when the athlete is perceived to be carrying the blame.
(A Lack of) Research on Sales. While the studies on stock-return effects undoubtedly provide helpful information-in the end, managers should evaluate any strategy based on whether it creates value for shareholders-we argue that attention for how endorsements and endorser events affect sales is much needed. In practice, most advertising executives will make decisions regarding endorsements based on an anticipated effect on their brand's revenues. Practitioners will want to weigh the investment they are planning to make in an endorser with the likely pay-off in additional revenues that the endorser will generate. They might want to understand how they can best reward endorsers, particularly when they are considering popular compensation models that are directly based on expected sales effects, such as additional fees when sales targets are reached, an outright share of sales, or bonus payments for victories. And practitioners might also want to evaluate whether enlisting an endorser can help them capture market share from competing brands -in other words, assess what kind of overall strategy best fits with celebrity endorsements-and how to allocate other marketing resources accordingly.
Finding answers to these questions based on the current research evidence on stock returns is challenging, also because those are collected at the firm-and not the brand-level (which is particularly problematic in the case of conglomerates that own many brands), and because information on fees paid to endorsers tends to be closely guarded (making it challenging to interpret stock-return effects as the result of the interplay between the revenues and costs associated with endorsements). Aside from anecdotal evidence of how sales react when brands sign endorsers or when those endorsers experience favorable or unfavorable events (e.g., Creswell 2008), answers are hard to come by.
Yet we have good reasons to theorize that endorsements might be effective in increasing sales, and that subsequent changes in the performance or reputation of an endorser could further move the needle. While extant research that relates celebrity endorsements to financial outcomes is largely free of any theoretical frameworks to explain the main effects, the literature on brand alliances, commonly defined as short-term or long-term associations of two or more individual brands, is highly relevant Ruekert 1994, Washburn, Till, and Priluck 2004) . The literature provides two main reasons why sales can be expected to benefit from celebrity endorsements. First, signing a high-profile endorser can help reassure consumers about the true quality of a product (Rao and Ruekert 1994) . The basic idea is that a brand is a signal of quality (Spence 1973) : because branded products that falsely claim high quality stand to lose investments in reputation and future profits, a branded product's claim about unobservable quality will likely be true (Rao, Qu and Ruekert 1999) . By extension, any event that improves an endorser's reputation -such as a notable achievement by an athlete -should provide consumers with further reassurance about the quality of the endorsed brand. Second, enlisting an endorser can help a firm enhance certain attributes, helping to differentiate its product from that of its competitors. For this reason, a "fit" or "match up" between brands in an alliance is seen as paramount to its effectiveness (e.g., Samu, Krishnan, and Smith 1999, also see Gwinner and Eaton 1999) . Because many firms seek to portray themselves as leaders in their markets, championships by athlete endorsers can be critical for this reason, too -it strengthens the athlete and partner brands' image as a "winner." Relevant in this respect is research in psychology which demonstrates people's need to "bask in reflected glory" by communicating one's associations with successful others (e.g., Cialdini et al. 1976, Snyder, Lassegard and Ford 1986) .
Both factors are likely to affect brand consideration and choice (Simonin and Ruth 1998, Erdem and Swait 2004) , and thereby sales.
MODELING APPROACH
Our modeling approach consists of three stages: we assess the impact of endorsement announcements and endorser achievements on sales, the impact of both events on stock returns, and the association between both metrics and their respective drivers.
Stage 1. The Impact on Sales
We model the impact of endorsements on sales using an intervention model. We do so for several reasons. First, an intervention model is ideally suited for a comparison of time-series observations before and after a certain "intervention" or "event" and a common methodology in the context of advertising effects (e.g., see Hanssens, Parsons and Schultz 2000) . Second, this type of model can help facilitate comparisons with the results of a stock-returns event study, as the conceptualizations and outputs for each model are relatively similar. Third, the model enables us to test, in a relatively parsimonious manner, to what extent sales effects are temporary or more permanent, which should be of prime interest to practitioners. Fourth, an intervention model allows us to control for general trends in sales, seasonality, and changes in the marketing mix such as price and advertising.
The Interventions. We distinguish two different types of interventions that may affect the endorsed firm's brand-level sales: (1) the firm entering into an athlete endorsement and (2) the athlete recording a major victory. We index time using t, and express the week in which an intervention takes place as T. As is common with this methodology, we test two specifications for each type of intervention: a "pulse" specification assumes a temporary effect at the intervention, while a "step" specification denotes a permanent jump to a new level after the intervention:
Pulse variable:
Step variable:
Modeling Sales. Because there is a substantial seasonal pattern in the data, we model sales in week t , Sales t , for the endorsed brand using an ARIMAX model with autoregressive and moving average terms and with yearly seasonality:
for each endorsement i separately. Here, ! 0 is the intercept, ! 1 and ! 2 are the parameters belonging to intervention vector X and predictor series Z, " 1 is the non-seasonal first-order autoregressive parameter, " 52 is the seasonal autoregressive parameter (with "52" referring to the week number), # 1 through # q are the moving average parameters of order 1 through q, # t is the general error term, and B is the backshift indicator. Estimation. We estimated equation 1.2 for each endorsement i separately, using at least 53 weeks of sales data before its formation and at least 52 weeks of sales data after that point. The long pre-intervention time series enabled us to identify the most suitable ARIMAX model from an analysis of the pre-intervention data, and then estimate the ARIMAX model with the intervention components jointly on the entire time series. We determined q for each series separately by minimizing the average absolute prediction error across the time series.
Because the intervention form is unknown ex ante, we first test whether a pulse or step model option generated a better fit based on Akaike's Information Criterion (AIC) and Schwarz's Bayesian Criterion (SBC) (McCleary and Hay 1980, Rasmussen et al., 2001) . That is, we started by comparing a model in which the endorsement announcements (X 0 ) are specified as a pulse variable (equation 1.1a) to one in which those announcements are specified as a step variable (equation 1.1b). The step function was the best-fitting model. Next, we compared two versions of that model: one in which the endorser-achievement events (X p ) are specified as pulse variables (with various lag structures), and one in which those events are specified as step variables. The step model performed best, based again on the AIC and SBC values (see Figure 2 for an illustration).
----- Figure 2 -----In our findings section below, we discuss results for the best-fitting model only. We also report on the estimates for a "competing-sales" model in which the dependent variable is the combined sales for all other brands in the focal brand's category (Rivals_Sales); we followed the exact same procedure to estimate those benchmark models.
Stage 2. The Impact on Firm Valuation
We use an event-study approach to assess the effect of endorsements on stock returns. Because event studies are a popular methodology in several business disciplines and the standard approach in extant research on the impact of endorsements on a firm's stock-market valuation to date, we are brief in our description.
The Event and Event Window. We perform two event studies. In the first, we define the event as the endorsement announcement. In the second, we define the event as the endorser having a noteworthy performance p, again indexed by 1 through n. In both studies the event day is defined as the day on which the event took place (unless the event occurred on a Saturday or Sunday or after trading hours; then the event day is defined as the first trading day following the event). We index returns in event time using d, and define d=D 0 to d=D 1 as the event window.
Normal and Abnormal Returns. We assess the impact of each type of event on a firm's valuation by estimating abnormal returns for the firm's security. For each endorsement i and time d:
where AR id are the abnormal returns, R id the actual returns, and E(R id ) the normal returns. We calculate normal returns using the so-called market model, which accounts for variability in the overall market returns (Campbell, Lo and MacKinlay 1997) :
where R pd is the return for the market portfolio m for security i over period d, $ 0i and $ 1i are the intercept and slope parameter of the market model, and % id denotes the error term. The market portfolio is captured by the index on which the firm's security is listed.
Estimation. We estimate normal returns using a period prior to the event, the estimation window, defined as d=D -2 to d=D -1 . The length of the estimation window ranges from 50 to 600 trading days in previous studies (e.g., Campbell et al 1997) . We opt for a length of 240 days, with d= [-250, -10] in our event study for the endorsement announcements. Given the relative frequency of major career events for top athletes, we opt for a shorter estimation window of 60 days (with d= [-70, -10] ) in our event study of endorser achievements. We test for the significance of ARs using a t-statistic generated by the average AR divided by its standard deviation (Brown and Warner 1985) .
Stage 3. The Effects and Their Drivers
We next examine how the effects on sales and stock returns relate to each other and evolve with each subsequent endorser achievement, while controlling for a set of possible drivers. Here, two observations underlie our choice of modeling approach. First, the same factors that drive effects on the endorsed brand's sales likely also determine those on the endorsed firm's valuation -we cannot a priori point to variables that would uniquely identify the effect on one outcome only. This follows from the idea that, in theory, advertising strategies affect the shape of the probability distribution of future sales income, and thus the firm's working capital requirements, and thus stock-price responses (e.g., Rao and Bharadwaj 2008) . Second, effects for the same endorsements (i.e. those involving the same partners) likely are correlated -for instance, even if the effects of an endorser's performances diminish over time, those for more powerful alliances between firms and athletes will probably have higher levels overall than those for less successful partnerships.
Assessing the drivers of the estimated effects of endorsement announcements on brand sales
) is rather straightforward. We can model both in a system of equations with identical regressors and correlated errors:
where FIRM, BRAND, ENDORSER, and ENDORSEMENT denote vectors of covariates, and ! i captures the error term.
The variables in the equations cover factors that, based on the literature on athlete endorsements and anecdotal industry evidence, can be expected to influence the effectiveness of such partnerships. We describe the FIRM in terms of its scale as measured by its market capitalization (Firm_Scale) as its resources and channel power could help it better monetize an endorsement, and count the number of endorsements which a firm holds at a particular time (Firm_Endorsements), as there may be diminishing returns in this respect (e.g., Tripp, Jensen and Carlson 1994) . Practitioners seeking athlete endorsements appear to bet heavily on -and pay a premium for -the very top-ranked athletes in particular sports, the agencies behind some of the best endorsers go to great lengths to craft their clients' images as "winners" (e.g., Elberse and Golod 2007) , and it is usually the leading firms that are able to sign superstar athletes. The BRAND and ENDORSER vectors therefore cover measures of the equity of both brands, Brand_Equity and Endorser_Equity, respectively, as well as their interaction term, Brand_Equity * Endorser_Equity. The vector ENDORSER further includes a dummy denoting whether the athlete competes in a sport with a large fan base (Endorser_Base), as the popularity of a sport affects the brand ally's reach (Ohanian 1991) , and we add a measure reflecting the number of years an athlete has been a professional athlete in a given week (Endorser_Lifecycle), to control for any career-lifecycle effects (Elberse and Golod 2007) . Finally, we add two variables that describe the ENDORSEMENT: a dummy indicating whether the deal extends beyond the domestic market (Endorsement_Global) because stock prices may respond to effects in international markets, and one reflecting whether the focal product is congruent with the athlete's activities (Endorsement_Fit, as in the "match up"
hypothesis, e.g., Erdogan, Baker and Tagg 2001 and Busler 2000) .
Examining the association and determinants of the effects of endorser achievements requires a more sophisticated model. In light of the likely correlation across dependent variables and across events for the same partnership over time, we estimate a multivariate linear mixed model:
where V hip denotes either the estimated effects on the focal brand's sales or the corresponding firm's valuation. The first dependent variable, denoted by h=1, is the difference between the intervention variables estimated in equation 1.2, denoted as
(We opt for the difference between estimated variables because that, given how the dummies are specified, reflects the increase in sales due to the endorser's performance). The second dependent variable, denoted by h=2, is ! ) A R ip , as estimated in equation 2.1 and 2.2. Each dependent variable h is specified at the level of an endorsement i and at the level of an athletic performance p, ranging from 1 to n. For each dependent variable, the parameter " 0h expresses the intercept, " 1h through " 5h the coefficients for the different (vectors of) variables, # hi the random part of the intercept in endorsement i, and $ hip the residual error. The multivariate specification allows us to draw conclusions about the correlations between the dependent variables, in particular the extent to which these correlations depend on the individual achievements for endorsers (the "individual level") or the endorsements themselves (the "group" level), and enables more powerful tests of the specific effects for single dependent variables (Snijders and Bosker 1999) .
The vector PERFORMANCE contains two variables: Performance_Order, which reflects the chronological order in which the performances 1 through n associated with each endorsement i take place, and Performance_Major, a dummy which captures whether the performance was a major event.
FIRM, BRAND, ENDORSER, and ENDORSEMENT are the same as in the equation 3.1.
Estimation. We estimate the model in equation 3.1 using ordinary least squares (Greene, 2000) . We generate heteroskedasticity-robust standard errors (MacKinnon and White 1985) . For the multilevel model in equation 3.2, we turn to the MLwiN software package (Snijders and Bosker 1999) ; we estimate the model using residual maximum likelihood (REML).
DATA
Sample and Dependent Variables. We performed an extensive media search to compile a database of past and present endorsements involving athlete endorsers and publicly traded firms.
We searched the websites of leading sport management agencies such as CAA, IMG, Octagon, and Wasserman, checked online newspapers and magazines, examined lists of the highest-paid athletes such as those published annually by Sports Illustrated and Forbes, and searched Fortune 500 firms' press releases. We determined the exact announcement date of each endorsement deal using Dow Jones Factiva, and confirmed the date using Sports Business Daily's news archive. (In the (few) instances where we could not reliably determine the announcement date, we omitted the observation). In total, our study covers 95 firms responsible for the focal brands, 178 athlete endorsers, and 341 endorsements formed between January 1990 and March 2008 (see Table 1 for descriptive statistics).
----- Table 1 -----We used Thomson Financial DataStream to compile daily stock prices for our sample of firms and for their daily market index. To avoid potential biases, we made sure that no pair of events involving one athlete or one firm overlapped in the period from the start of their estimation window to the end of the longest event window; if they did overlap, we excluded both observations. This led to the stated total of 341 brand endorsements.
To construct a measure of sales for the endorsed brands, we obtained dollar sales data from Nielsen's HomeScan panel, which covers 120,000 households scanning all their in-home and out-ofhome purchases. Our data comprise weekly sales in the U.S. from January 2004 to October 2009
for 35 consumer product categories, including bottled water, cameras, chewing gum, cosmetics, fragrance, shaving needs, soft drinks, and phones. Sales are specified at the brand and product level, allowing us to examine sales for the endorsed brand as well as all competing brands in the same category. Since not all brands in our study fall into the product categories and the period for which we have sales data, our "brand sales" sample covers a subset of 51 endorsements and a combined 14,280 weekly observations for those partnerships.
For all athletes in our study, we compiled data on major achievements across sports such as baseball, basketball, boxing, car racing, football, golf, swimming, soccer, and tennis. We did so by first selecting the highest-profile events in each of these sports (e.g., Grand Slam tournaments in tennis and the play-off finals in basketball, coded as "major" events) and where available also second-tier events (e.g., non-Grand Slam ATP tournaments, coded as "minor" events), and then by assessing whether the athletes in our sample performed in those events over the course of their endorsement contract and if so, by selecting those instances in which one of the athletes (or the teams to which they belonged) prevailed. We used the respective sports leagues and various other publicly available sources to do so. This procedure yielded a total of 596 performances; for 130 (42 major and 88 minor championships) we have both sales and stock return information.
Other Variables. We further constructed variables describing the endorsed firm, the endorsed brand, the endorser, and the endorsement. We used Nielsen HomeScan data to compute the weekly intensity of price promotions for each of the focal brands (Brand_PricePromo) and for their set of in-category competitors (Rivals_PricePromo), by calculating the share of sales sold on promotion. Nielsen also provided us with monthly advertising expenditures for each of the brands in the 35 product categories for which we have sales data; we allocated the expenditures evenly across the weeks in each month to create a measure of weekly advertising for the focal brand (Brand_Advertising) and again for the set of competing brands in that brand's category (Rivals_Advertising). We used the same data source to compile data on the endorsed brand's equity at the time an endorsement was announced: we express the brand's equity (Brand_Equity) in terms of its share of dollar sales in its product category. We computed the endorser's brand strength (Endorser_Equity) by allocating a performance ranking using listings such as the ATP ranking for tennis, the FIFA Player of the Year voting results for soccer, and (position-specific) player statistics compiled by the NFL. The variable reflects an individual player's relative performance, expressed as a ranking, in the season prior to the date on which the player entered an endorsement contract. We inverse the ranking so higher values indicate a more favorable record. Using various public sources, we constructed a dummy that has a value of one for the five major sports (basketball, baseball, football, golf, and tennis) represented in our sample (Brand_Base) and a measure reflecting the number of years an athlete had been a professional athlete at the time of the endorsement announcement or endorser achievement (Brand_Lifecycle). Drawing on Thomson Financial
DataStream, COMPUSTAT, and press releases, we calculated a firm's market value (Firm_Scale) in tens of billions of dollars, calculated by multiplying the number of outstanding shares as listed in the firm's last annual report with the firm's stock price on the last day of the estimation window. We turned to press releases and other public sources to count the number of endorsement deals a firm holds at each point in time (Firm_Endorsements), and examine whether the endorsement deal extended beyond the domestic market (Endorsement_Global). Finally, we used coders to assess whether the product advertised was congruent with the athlete's sports activities (Endorsement_Fit, with, say, a sports-apparel or sports-equipment deal being coded as a "1" while a fragrance deal would receive a score of "0").
FINDINGS

Impact on the Brand's Sales
Validating our modeling specification, the first-order and seasonal autoregressive terms are statistically significant in the ARIMAX models estimated for each of the 51 endorsements' time series, and the first-order moving-average term is significant in 49 of those (see Table 2 ). The parameter estimates belonging to Brand_Advertising, Brand_PricePromo, Rivals_Advertising, and
Rivals_PricePromo have average t-statistic values that make them significant as well (albeit Rivals_Advertising only at a 10% level), suggesting these variables are relevant control factors.
----- Table 2 -----
Do Endorsements Drive Up Sales?
The estimates for % 1.0 , the parameter belonging to X 0 (the variable denoting the start of the endorsement), show that a firm's decision to hire an endorser generally has a positive impact on the firm's focal brand's sales (see Model I in Table 2 ). The estimate's average value, 0.20, indicates that weekly sales increase with just over $200,000 over the course of the duration of the endorsement (note that sales are measured in millions of dollars) as compared with what was to be expected based on historical sales, even after controlling for any changes in advertising and pricing strategies. That corresponds with over $10 million in added sales annually. The increase reflects around 4% of the average weekly sales for the brands in our sample. Table 2 is that the estimate % 1.0 is positive and significant at the 1% level for 43 of the 51 (i.e. 84%) endorsements in our sample, negative and significant in three cases, and statistically indistinguishable from zero for five partnerships. Overall, though, the evidence undeniably points to a positive impact of athlete endorsements on the endorsed brand's sales.
Not reported in
The results further reveal that, on average, competitors' sales do not noticeably respond to the endorsement, judging by the average estimate for % 1.0 (see the bottom half of show that an endorsement strategy generally leads to increased sales for the focal brands, both in absolute terms and relative to their competitors.
Do Endorser Achievements Increase Sales?
What happens when the athlete endorser adds to his or her reputation by capturing a championship? The average estimates for the parameters % 1.1 through % 1.5 , which belong to the intervention variables X 1 through X 5+ (the variables reflecting the endorser achievements), are statistically significant and positive, ranging from 0.21 (for X 1 ) to 0.36 (for X 5+ ) (see Model II in Table 2 ). Given how the step variables were constructed, we can interpret the difference between the average values for the coefficients belonging to X 0 and X 1 (0.14 and 0.21) as being reflective of the sales increase due to the first performance. That is, when the athlete captures a championship during the endorsement, weekly sales are expected to increase with an additional ($210,000 -$140,000 =) $70,000 per week. Because the average estimate for the coefficient belonging to X 2 is 0.24, the second is expected to generate another $30,000, and so on.
According to the average estimates, sales are expected to increase with each additional achievement.
At first glance the values do not show a strong "decreasing-returns" pattern -for instance, the jump from X 2 to X 3 is greater than the jump from X 1 to X 2 -but because the intervention variables represent a varying mix of major and minor events, it is difficult to come to definitive conclusions based on just the listing of estimates. Even athlete endorsers that do not capture any championships create significant value, however: the parameter estimate belonging to X 0 is 0.14, which means that (holding all else equal) weekly sales in the period after an endorsement partnership is started are on average $140,000 higher than historical sales would predict. This could for instance be due to the athletes in these partnerships benefiting from a "winning" or "high-quality" reputation built up in the period prior to entering into the endorsement, or to other favorable attributes they may represent. We examine these effects and their drivers in greater detail in the third modeling stage.
Lastly, again, rivals brands do not appear to benefit from any sales uptakes (see the bottom half of Table 2 ). Overall, no significant effects can be found.
Impact on the Firm's Stock Returns
The event studies reveal the impact of endorsement announcements and endorser achievements on a firm's stock-market valuation (see Table 3 ).
----- Table 3 -----
Do Endorsements Drive Up Stock Returns?
The finding jumping out here is that, across the 341 endorsements in the sample, an endorsement is associated with an average abnormal return (AR) of 0.23% on the announcement day, a result that is statistically significant at the 1% level (p=0.01). Thus, entering into an endorsement increases a firm's valuation. The ARs in the days surrounding the event day are statistically indistinguishable from zero, and the cumulative abnormal returns (CARs) calculated over various windows beyond the event day itself are not statistically significant. This implies that the event is quickly incorporated into the stock price, and there is no prolonged effect.
Do Endorser Achievements Increase Stock Returns?
When it comes to the impact of endorsers' athletic achievements, we find that such performances significantly and positively impact the endorsed firms' stock prices (see the right half of Table 3 ). The 596 events are associated with an average AR of 0.08% on the event day and a CAR of 0.14% on the event and subsequent day; the latter is significant at the 1% level. Major events (i.e. first-tier championships) alone are associated with a CAR of 0.16%, which again is significant at the 1% level. Minor events do not trigger significant stock-price changes. An examination of the distribution of ARs again shows it is skewed to the right. Evidence of a prolonged stock price effect also does not emerge.
The pattern in the ARs, and specifically the finding that the ARs leading up to event day are statistically insignificant, may point to the importance of winning championships -not, say, coming in second or reaching the semi-finals in a tournament. We observe a sudden shock at the time of a victory -not a steady climb of those prices as the endorser advances into a tournament and gets more press attention, which we would expect to see if a higher level of publicity or exposure for an endorser alone causes a firm's stock returns to increase.
Because the two-day CAR for endorser performances is higher than the one-day AR and significant at a 1% level, we will use this estimate as the corresponding dependent variable (denoted
A R n ) in the next modeling stage.
The Association, Temporal Pattern, and Drivers of Sales and Stock-Return Effects
Lastly, our study provides insight into the association, temporal pattern, and drivers of sales and stock-price effects (see Table 4 ).
----- Table 4 Three statistics regarding the strength of the association between the endorser-performance intervention dummies (
noteworthy. First, the reported correlation coefficient between both variables is 0.18, which again is significant at a 5% level but relatively low. The residual correlation coefficient at the endorsement level and the endorser-performance level are 0.33 and 0.15, respectively. The random effects for sales and stock returns thus are stronger correlated at the level of the endorsements than at the level of the events involving athletes in those endorsements. This suggests that, even after controlling for the FIRM, BRAND, ENDORSER and ENDORSEMENT variables, there are common unobserved forces at the "group" level that determine sales and stock-return effects -hence the need for a linear mixed modeling approach.
Do Endorsers' Performances Have Decreasing Returns? The variable
Performance_Order helps us understand how the positive effects of performances by a firm's endorser evolve over time. The parameter " 1 in the sales equation has an estimate of -0.05, meaning that each subsequent "winning" performance by an athlete will result in $50,000 less of a rise in weekly sales than the previous performance by that same athlete under the same partnership with a firm (controlling for, among other things, the profile of such events though the variable Performance_Major). The relevant parameter in the stock-returns equation, however, has an estimate that is not significantly different from zero. In other words, the response of investors does not display such decreasing returns. One explanation could be that traders see these performances as a credible signal not just of the endorser's current but also of its future value -their thinking might be that if Maria Sharapova wins a Grand Slam, she might be capable of winning another, and even if the immediate benefits might not warrant a certain level of returns, they are betting on possible future sales and profits. But it could also be that traders are simply overestimating the significance of the impact of subsequent performances on earnings during the endorsement.
All in all, we find that the effects of endorser achievements decrease with each subsequent performance for brand sales -but not for stock returns. These patterns are visible in our data if we control for the nature of the performance, through Performance_Major (see Figure 3 ).
-----Figure 3 -----
What Are Drivers of Sales and Stock-Return Effects?
When it comes to other drivers of both effects, the variables measuring the equity of the focal brand and the reputation of the endorser are significant across equations, with stronger brands generally yielding greater benefits (see Table 4 ). Focusing first on the effects of the endorsement announcements (
parameter estimates belonging to Brand_Equity in the sales and stock-returns equations are 0.25 and 0.47, respectively. This means that for each 10% higher share the brands have in their category, endorsements will yield $25,000 higher weekly sales, and 0.05% higher abnormal stock returns. The parameters belonging to Endorser_Equity are significant and positive as well, indicating that the stronger the athlete's reputation is, the more positive the effects of endorsements on sales and stock returns are. According to the estimates for Endorser_Equity, 0.006 and 0.008, respectively, the difference between entering an endorsement with a top-ranked athlete versus one that just makes it into the top 10 is $60,000 in weekly sales and 0.08% in stock returns. Thus, athletes with a stronger reputation as a "winner" are more effective endorsers. Interestingly, the advantages are especially strong for partnerships that involve top consumer-goods brands and top athletes. The positive estimates for the interaction term Brand_Equity * Endorser_Equity, are 0.06 and 0.02 in the sales and stock-returns equation, respectively. Simulations show the effect to be substantial: for instance, for a focal brand with a 25% market share, the interaction effect adds around $100,000 in weekly sales to the jump from a number-ten-ranked to a number-one ranked endorser.
Our analysis of the effects for the endorser performances yields similar results for the brand-
Here, again, the parameters belonging to Endorser_Equity are significant and positive, indicating that the effects of athletic performances on sales and stock returns are stronger the better the reputation of athlete already is. And, again, both the estimates for Brand_Equity and the Brand_Equity * Endorser_Equity interaction terms are significant and positive, indicating that top-ranked brands and athletes make especially suitable partners. For the stock-
A R n ), the parameters for Brand_Equity and Endorser_Equity again are positive, meaning events involving higher-equity brands and athletes yield higher abnormal returns.
Judging by the relatively low estimate for Endorser_Equity, 0.002, the absolute effect is small for athletes. This may be because, in theory, traders only respond to new information: a Grand Slam win by Roger Federer, long the world's best tennis player, should jolt traders less than a win by his Swiss compatriot Stanislas Wawrinka, who has never won a major individual title, simply because a Federer victory is almost to be expected (and therefore already incorporated in the stock price).
Furthermore, we do not find any significant interaction effects here: the parameter belonging to Brand_Equity * Endorser_Equity is not significantly different from zero.
CONCLUSIONS
Celebrity, and in particular athlete, endorsements are big business: Nike alone is thought to have spent around $475 million annually on athlete endorsements as part of its $1.7 billion advertising budget in 2006 (Rovell 2006) , but many companies outside the sports-apparel industry are active participants as well. In this study, we find validation for the use of celebrity endorsers as an advertising strategy: a firm's decision to enlist an athlete endorser generally has a positive pay-off in brand-level sales -in an absolute sense and relative to the firm's competitors -and increases the firm's stock returns. Signing the kinds of endorsers that featured in our research on average generates a 4% increase in sales -which corresponds with around $10 million in additional sales annually -and nearly a 0.25% increase in stock returns. While endorsements improve sales for the focal brands, they do not move the needle for competing brands in the category. In addition, our findings reveal that an athlete's performance can affect the rewards gained by a firm over time: sales and stock returns jumped noticeably with each major championship won by the athlete. The focal brand's equity and the endorser's reputation drive both effects: endorsements between a top-ranked consumer-goods brand and a top-ranked athlete yield the largest increases in sales and stock returns.
Our findings reveal that there is a relatively weak association between outcomes: the impact for a given brand at a given point in time can differ sharply depending on which metric -sales or stock returns -is considered. Over time, stock returns and sales also display different patterns: while there are diminishing returns to sales benefits -with, say, each subsequent Grand Slam that tennis star Maria Sharapova wins, sales for the brands she endorses will rise slightly less -stock-return effects are relatively constant over time. And the attributes of firms, brands, and athletes that predict higher stock returns only partially overlap with those associated with higher sales, and vice versa.
MANAGERIAL IMPLICATIONS
Our study should help practitioners who are considering signing celebrity endorsers or who seek information on how to best structure and manage such partnerships over time. Several implications stand out:
• First, the observed positive pay-off in terms of brand-level sales and firm-level stock returns should give advertising executives confidence in the overall effectiveness of an endorsement strategy. In general, enlisting the help of celebrity endorsers pays off.
• Second, the finding that sales increase in an absolute sense and relative to the firm's competitors suggests that an endorsement strategy fits a marketing campaign aimed at increasing market share. Fears that celebrity endorsers help competing brands in the category as much as the endorsed brand appear unjustified, our study shows. Where applicable, practitioners should be ready to support an endorsement-advertising strategy with higher distribution levels.
• Third, when it comes to selecting endorsers -an activity that advertisers should approach with care because making the right choices can substantially affect the rewards gained -our results suggest that paying a premium for the most sought-after endorsers seems worthwhile in terms of both sales and stock returns. In fact, betting on top-ranked athletes with a reputation as "winners" is beneficial in two ways: in the short term it leads to the highest financialperformance effects, and in the long run it maximizes the likelihood of more notable achievements, leading to further gains in sales and stock returns. At the same time, practitioners should be aware that the strong competition for those endorsers comes with a chance of overspending, and thus eroding the profitability of the strategy.
• Fourth, in structuring contracts with endorsers, our finding that there are positive but decreasing returns to sales could be something practitioners may want to reflect in their contracts with endorsers. For instance, bonus payments that rise with each subsequent major championship for the athlete may not be the right format, and neither are long-term or even lifetime contracts.
Precisely because sales effects decrease over the course of the duration of the contract, the return on investments in such contracts will likely become less favorable for the advertiser over time. In fact, endorsement contracts that extend well into the future may only be worthwhile if the firm focuses more on its market capitalization and relationships with the investment community -after all, our results show, stock-return effects to endorser achievements are relatively constant over time.
• Fifth, our study highlights that practitioners will generally likely face trade-offs in maximizing sales and stock-return performance. This in turn should affect how they communicate choices regarding endorsement strategies to the business and investment community. Even simply being aware of the differential impact of endorsements on stock returns and sales might help managers more effectively inform investors and other constituents.
Finally, our study also has implications for celebrities and their agents. For instance, our results provide justification for an emphasis on building and maintaining a "winning" record and image -this should translate into a higher value at the time endorsement contracts are signed. And more generally, knowing the likely pay-off to endorsements should help agents and their celebrity clients in better structuring and negotiating deals, thus allowing them to capture a fair share of the value they create. Note: Figure 2 displays actual sales for the brand Gatorade (the black line) as well as predicted sales generated using the ARIMAX model (the gray line). Data for the full sample period from January 2004 onwards were used in fitting the model. The graph also captures important events in the brand's alliance with tennis player Maria Sharapova: the formation of the alliance (X0), as well as a second-tier and a first-tier victory for the athlete, respectively (X1 and X2). The figure illustrates the estimation process that led to both types of events being specified as step variables. The figure also provides an example of the resulting coding for the intervention variables (X) over the course of the study period: X0 is coded "1" between the announcement of the endorsement and Sharapova's first achievement and "0" otherwise, X1 is coded "1" between the first and the second achievement, and so on. Table 2 displays summary statistics for the intervention models that were estimated using time series for each of the 51 endorsements separately; 14,280 weekly observations were used in total. The X1 through X5+ variables cover a total of 130 athleteendorser performances. In light of the limited number of endorsements with more than 5 notable athletic performances, we limit our reporting to five such variables, X1 through X5+., with the latter covering all fifth and higher performances. The top half of the table reflects models for the focal brand's sales; the bottom half those for rivals' sales. Sales are expressed in millions of dollars. Significance levels are given by * p=0.10, ** p=0.05, and *** p=0.01. Table 3 displays the average and cumulative abnormal returns for selected event windows for the sample of 341 endorsement announcements (on the left) and 596 athlete-endorser performances (on the right). Further tests with other event windows did not yield other significant average cumulative abnormal returns. Significance levels are given by * p=0.10, ** p=0.05, and *** p=0.01. Table 4 presents the results of the system of equations expressed in equation 3.1 (estimated by OLS, with heteroskedasticityrobust standard errors) and the multivariate linear mixed model reflected in equation 3.2 (estimated by REML). Results for the former are displayed in the top half; data for 51 endorsements were used in the estimation. Results for the latter are in the bottom half; data for 130 endorser performances were used in the estimation. Significance levels are given by * p=0.10, ** p=0.05 and *** p=0.01. .
